Talk:Neonatal lupus erythematosus

Article categorization

This article was categorized based on scheme outlined at WP:DERM. kilbad (talk) 02:04, 18 December 2008 (UTC)

Made changes to the article so that a section for pathogenesis, clinical manifestations, diagnosis, and manifestations could be added. Spikeandwave (talk) 18:01, 22 March 2022 (UTC)

Sjogren's syndrome

The antibodies that cause this condition, SSA and SSB, are typically associated with Sjogren's syndrome, and thus neonatal lupus is not exclusively found in the neonates of women with SLE. Pregnant women with Sjogren's syndrome and the anti-Ro/La or SSA/SSB antibodies are at risk of having a baby affected by either neonatal lupus affecting the skin or the heart (heart block). Neonatal lupus is a misleadingly-named disease, because it isn't lupus found in a baby (I don't think that adults with lupus have heart block), and it isn't exclusively associated with lupus in the mother, and it isn't really neonatal and apparently can't be detected by examination at birth.

Updated the article to make this distinction and included references for such content.Spikeandwave (talk) 18:04, 22 March 2022 (UTC)

Photosensitivity of the rash

The face rash associated with this condition typically develops at around six weeks after birth as a redness in the skin surrounding the baby's eyes (not bruising). The severity and duration of the face rash can certainly be influenced by sun exposure, and a photosensitive persistent rash can also be found in other areas of the body. Such rashes can persist for most of baby's first year. Medical advice should be sought regarding avoiding sun exposure in babies with neonatal lupus and requirements for appropriate levels of vitamin D.

neonatal lupus

How does it affect audits. what symptoms does it present? 2601:CA:201:11B0:EDD0:133E:D5E:75A4 (talk) 16:30, 9 September 2021 (UTC)

Wiki Education assignment: 2021-22 TCOM WikiMed Directed Studies

This article was the subject of a Wiki Education Foundation-supported course assignment, between 28 February 2022 and 25 March 2022. Further details are available on the course page. Student editor(s): Spikeandwave (article contribs). Peer reviewers: Shar.Ajaykumar2022.

Changes/Improvement

Changes made to the article include adding sections for pathogenesis, clinical manifestations, diagnosis, and management and content for each. The lead was updated to reflect these changes. UpToDate and two textbooks were used as resources for the new content added. These resources are peer-reviewed and provide an overview of the topic. The page can still be improved by adding an epidemiology section as well as adding more information to each section. The addition of resources can help strengthen this article.Spikeandwave (talk) 18:16, 22 March 2022 (UTC)

Peer Review

The article sounds great! There are a couple of areas where sentences can be a little confusing/long and splitting them up may make it easier to understand. The second sentence under pathogenesis could be split, as could the sentences in the skin clinical manifestations paragraph. Under management, it might help to give examples of supportive care; people in the medical field will understand but those not in the field may not know. Everything in the article was written in a neutral voice and there are great hyperlinks to show readers examples of clinical manifestations. I believe it gives a great overview of the topic! Shar.Ajaykumar2022 (talk) 16:52, 21 March 2022 (UTC)

Thanks for the review! I appreciate the suggestions and was able to make those changes. Spikeandwave (talk) 18:21, 22 March 2022 (UTC)